Investing.com -- ConAgra Brands lowered its fiscal 2025 financial outlook due to supply constraints and foreign exchange headwinds, the company announced ahead of its upcoming presentation at the Consumer Analyst Group of New York (CAGNY) Conference.
The stock has declined over 5% in premarket trading following the news.
The packaged foods giant now expects organic net sales to decline by approximately 2%, compared to its previous forecast of a decline between 1.5% and flat growth.
Adjusted operating margin has been revised down to 14.4% from 14.8%, while adjusted earnings per share (EPS) are now projected at $2.35, down from the prior range of $2.45 to $2.50.
CEO Sean Connolly said ConAgra remains committed to long-term growth, despite near-term disruptions.
“We are pleased with the strong and consistently improving demand we have experienced this year as a result of those investments. While we've faced recent challenges servicing that demand, our investments in infrastructure and strategic partnerships position us for long-term success,” Connolly stated.
The company cited manufacturing challenges at a key facility producing chicken for frozen meals as a significant factor behind its revised outlook.
ConAgra temporarily halted production after noticing product quality inconsistencies and has since resumed operations at a slower pace while also working with third-party manufacturers.
Additionally, strong demand for frozen vegetables led to inventory shortages, prompting ConAgra to restrict product allocation through March 2025 to rebuild supply.
Despite the setbacks, ConAgra maintains its long-term financial targets and plans to modernize the affected chicken processing facility by early fiscal 2026.
Related Articles
ConAgra Brands lowers 2025 sales and profit guidance, stock drops
Venture Global stock: Wall Street starts coverage on LNG exporter after IPO
PainReform stock soars on DeepSolar acquisition
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。